US STOCK
AZN Stock Analysis
US stocks · market data · technical indicators
AstraZeneca PLC
AZNUS stocksQuote delayed 15 min
10/27 上午06:16 updated
$172.06
+0.57+0.33%
Open
$171.54
High
$172.37
Low
$170.68
Volume
415.17萬
AZN price history
+3.56%Open
166.15
Latest
172.06
High
172.57
Low
155.82
Average
163.11
Advertisement
Financial snapshot
AZN - AstraZeneca PLC
EPS
6.69USD
Forward EPS
11.34USD
P/E
25.72x
Forward P/E
15.17x
P/B
5.31x
ROE
21.97%
ROA
8.21%
Operating margin
23.46%
Profit margin
17.02%
Revenue growth
6.40%
Earnings growth
2.50%
Dividend yield
1.87%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $15.38B | $15.29B | $15.50B | $15.19B | $14.46B | — |
| Gross profit | $12.86B | $12.61B | $12.38B | $12.39B | $11.98B | — |
| Operating income | $3.16B | $4.25B | $2.98B | $3.58B | $3.51B | — |
| Net income | $2.51B | $3.08B | $2.33B | $2.53B | $2.45B | — |
| Basic EPS | 1.61 | 1.99 | 1.50 | — | 1.58 | 1.88 |
| Diluted EPS | 1.61 | 1.97 | 1.49 | — | 1.57 | 1.87 |
Estimates vs actuals
Next earnings
2026-10-30
EPS estimate
—
Revenue estimate
$16.00B
Last surprise
+4.85%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-30 | 2.58 | Not reported | — |
| 2026-07-27 | 1.25 | 1.32 | +4.85% |
| 2026-04-29 | 1.27 | 1.29 | +1.43% |
| 2025-11-06 | 1.13 | 1.19 | +4.88% |
| 2025-07-29 | 0.88 | 0.79 | -10.71% |
| 2025-04-29 | 1.12 | 1.25 | +11.59% |
| 2025-02-06 | 1.04 | 1.05 | +0.84% |
| 2024-11-12 | 1.03 | 1.04 | +1.13% |
| 2024-07-25 | 0.99 | 0.99 | -0.38% |
| 2024-04-25 | 0.95 | 1.03 | +8.42% |
| 2024-02-08 | 0.76 | 0.73 | -4.92% |
| 2023-11-09 | 0.82 | 0.87 | +5.32% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $547.4M | 0.01% |
| CITADEL ADVISORS LLC | 2026-06-30 | $183.9M | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $62.4M | 0.05% |
| STATE STREET CORP | 2026-06-30 | $49.1M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$206.66
Target range
$158.00 – $240.00
Implied upside
20.11%
Strong buy
2
Buy
7
Hold
2
Sell
1
Strong sell
0
Dividends
Annual yield
1.88%
Frequency
Semi-annual
Recent payouts
- 2026-08-07$1.0600
- 2026-02-20$2.1700
- 2025-08-08$0.5050
- 2025-02-21$1.0300
Advertisement